Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Reactive Arthritis

Robert D. Inman, MD  |  Issue: October 2010  |  October 1, 2010

This study has raised important issues in several contexts. First, there is the conceptual issue that intraarticular persistence of pathogens may trigger a chronic inflammatory process that may be sustained, possibly for years. Secondly, the ambiguity in nomenclature becomes readily apparent, as it has been the case for Lyme arthritis. If the inflammatory process is terminated with antibiotic treatment, it could be argued that the treated condition meets a reasonable operational definition of septic arthritis, rather than reactive arthritis. Finally, the clinical implications are significant. The subjects in this study had a long-standing seronegative arthritis that had proved refractory to both nonsteroidal antiinflammatory drugs and disease-modifying anti-rheumatic drug treatment. This raises a very pertinent clinical question: How many patients currently classified as undifferentiated SpA might be effectively treated with antibiotics? It is a question for which Dr. Osler would have urged an answer.

Send Us a Letter!

Contact us at:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

David Pisetsky, MD, PhD, physician editor
E-mail: [email protected]

Dawn Antoline, editor,
E-mail: [email protected]

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Phone: (201) 748-7757

The Rheumatologist welcomes letters to the editor. Letters should be 500 words or less, and may be edited for length and style. Include your name, title, and organization, as well as a daytime phone number.

Self/Nonself Complexities Arising

In the original formulation of the underlying principles of the innate immune response, perfect self/nonself discrimination was proposed as the one of the cardinal features because the pathogen associated molecular patterns (PAMPs) recognized by host innate immune receptors were so different from endogenous host ligands so as to never allow a case of mistaken identity. A PAMP was the molecular passport of an alien.

But what should happen in the event that an alien has not only invaded our home and native land, but has become enculturated and fully assimilated into the society? Such was the case with the bacterial symbionts of antiquity that invaded eukayotic cells, set up distinct societies, and in time became mitochondria. But, a genetic footprint of this event was left behind: our mitochondrial DNA retains significant sequences of bacterial DNA.22 With respect to immune recognition, this is far more profound—and more unnerving—than molecular mimicry of host and microbial determinants. This is molecular identity of host and microbial determinants.

What would transpire if the mitochondrial DNA were released systemically, as might occur following trauma? That might occasion a response that was indistinguishable from sepsis, which seems unlikely—yet that is precisely what occurs. The binding of mitochondrial DNA to TLR9 on the surface of neutrophils initiates activation of neutrophils and release of IL-8 in a way that looks just like an infection (see Figure 2, above left).23 Indeed, infusion of mitochondrial DNA alone initiates an intense pneumonitis similar to that seen in the systemic inflammatory response syndrome that occurs after trauma. This recognition is changing the landscape of the concept of infection. Perhaps the enemy has been lurking within all along. With respect to host immune response, perhaps we have met the enemy—and it is us.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:Clinical Criteria/GuidelinesConditions Tagged with:ImmunityInfectionReactive arthritis

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition

    January 1, 2014

    Joint pain and swelling flare up in a 14-year-old boy who tests positive for inflammation, thrombocytosis, and human leukocyte antigen B27

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

    May 20, 2022

    HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences